BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34362951)

  • 21. Identification of biomarkers for the prediction of relapse‑free survival in pediatric B‑precursor acute lymphoblastic leukemia.
    Jing W; Li J
    Oncol Rep; 2019 Jan; 41(1):659-667. PubMed ID: 30542734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
    Kawamata N; Ogawa S; Seeger K; Kirschner-Schwabe R; Huynh T; Chen J; Megrabian N; Harbott J; Zimmermann M; Henze G; Schrappe M; Bartram CR; Koeffler HP
    Int J Oncol; 2009 Jun; 34(6):1603-12. PubMed ID: 19424578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
    Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
    Andersson N; Bakker B; Karlsson J; Valind A; Holmquist Mengelbier L; Spierings DCJ; Foijer F; Gisselsson D
    Cancer Res; 2020 Apr; 80(7):1512-1523. PubMed ID: 32041836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
    Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
    Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal evolution of acute leukemia genomes.
    Jan M; Majeti R
    Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
    Sanchez R; Ayala R; Alonso RA; Martínez MP; Ribera J; García O; Sanchez-Pina J; Mercadal S; Montesinos P; Martino R; Barba P; González-Campos J; Barrios M; Lavilla E; Gil C; Bernal T; Escoda L; Abella E; Amigo ML; Moreno MJ; Bravo P; Guàrdia R; Hernández-Rivas JM; García-Guiñón A; Piernas S; Ribera JM; Martínez-López J
    Ann Hematol; 2017 Jul; 96(7):1069-1075. PubMed ID: 28451802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
    Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
    PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic abnormalities associated with the relapse of childhood leukemia].
    Yoshida K
    Rinsho Ketsueki; 2016 Jul; 57(7):919-24. PubMed ID: 27498739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal whole-genome sequencing reveals the evolution of MPAL.
    Zhang Y; Kang Z; Lv D; Zhang X; Liao Y; Li Y; Liu R; Li P; Tong M; Tian J; Shao Y; Huang C; Ge D; Zhang J; Bai W; Wang Y; Liu Q; Li Z; Yan J
    Cancer Genet; 2020 Jan; 240():59-65. PubMed ID: 31786363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
    Ebinger S; Özdemir EZ; Ziegenhain C; Tiedt S; Castro Alves C; Grunert M; Dworzak M; Lutz C; Turati VA; Enver T; Horny HP; Sotlar K; Parekh S; Spiekermann K; Hiddemann W; Schepers A; Polzer B; Kirsch S; Hoffmann M; Knapp B; Hasenauer J; Pfeifer H; Panzer-Grümayer R; Enard W; Gires O; Jeremias I
    Cancer Cell; 2016 Dec; 30(6):849-862. PubMed ID: 27916615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia.
    Mat Yusoff Y; Ahid F; Abu Seman Z; Abdullah J; Kamaluddin NR; Esa E; Zakaria Z
    Mol Cytogenet; 2021 Sep; 14(1):45. PubMed ID: 34560908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas.
    Jiang Y; Redmond D; Nie K; Eng KW; Clozel T; Martin P; Tan LH; Melnick AM; Tam W; Elemento O
    Genome Biol; 2014 Aug; 15(8):432. PubMed ID: 25123191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
    Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
    Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CREBBP mutations in relapsed acute lymphoblastic leukaemia.
    Mullighan CG; Zhang J; Kasper LH; Lerach S; Payne-Turner D; Phillips LA; Heatley SL; Holmfeldt L; Collins-Underwood JR; Ma J; Buetow KH; Pui CH; Baker SD; Brindle PK; Downing JR
    Nature; 2011 Mar; 471(7337):235-9. PubMed ID: 21390130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.